HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Histogenesis of ovarian malignant mixed mesodermal tumours.

Abstract
The histogenesis of ovarian malignant mixed mesodermal tumours, which includes the concept of metaplastic carcinoma, is controversial. Four such tumours were examined for evidence of metaplastic transition from carcinoma to sarcoma using morphology and reticulin stains. Consecutive sections were stained immunohistochemically using cytokeratin and vimentin to determine whether cells at the interface between carcinoma and sarcoma expressed both cytokeratin and vimentin. There was no evidence of morphological, architectural, or immunohistochemical transitions from carcinoma to sarcoma in the four tumours studied. This suggests that ovarian malignant mixed mesodermal tumours are not metaplastic carcinomas but are composed of histogenetically different elements.
AuthorsT J Clarke
JournalJournal of clinical pathology (J Clin Pathol) Vol. 43 Issue 4 Pg. 287-90 (Apr 1990) ISSN: 0021-9746 [Print] England
PMID2160478 (Publication Type: Journal Article)
Topics
  • Adenocarcinoma (pathology)
  • Aged
  • Cell Transformation, Neoplastic (pathology)
  • Cystadenocarcinoma (pathology)
  • Female
  • Humans
  • Neoplasms, Germ Cell and Embryonal (pathology)
  • Ovarian Neoplasms (pathology)
  • Rhabdomyosarcoma (pathology)
  • Sarcoma (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: